Novacyt S.A. (NVYTF) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Novacyt S.A., an international specialist in clinical diagnostics, has reported its monthly liquidity update, revealing that Invest Securities bought 69,420 and sold 101,521 of the company’s ordinary shares within a price range of €0.51 to €0.85 in April. As of April 30, 2024, Novacyt’s total number of ordinary shares stands at 70,626,248, which shareholders use to assess their notification requirements for changes in company interest. Novacyt’s diverse portfolio includes clinical diagnostics, genomic medicine, and environmental testing services, with a commercial presence in over 65 countries.
For further insights into NVYTF stock, check out TipRanks’ Stock Analysis page.